Literature DB >> 22684537

Anticlastogenic effect of β-glucan, extracted from Saccharomyces cerevisiae, on cultured cells exposed to ultraviolet radiation.

Ariane Fernanda da Silva1, Rodrigo Juliano Oliveira, Andressa Megumi Niwa, Gláucia Fernanda Rocha D'Epiro, Lúcia Regina Ribeiro, Mário Sérgio Mantovani.   

Abstract

β-glucan is an important polysaccharide due to its medicinal properties of stimulating the immune system and preventing chronic diseases such as cancer. The aim of the present study was to determine the anticlastogenic effect of β-glucan in cells exposed to ultraviolet radiation (UV). Chromosome aberration assay was performed in drug-metabolizing cells (HTC) and non drug-metabolizing cells (CHO-K1 and repair-deficient CHO-xrs5), using different treatment protocols. Continuous treatment (UV + β-glucan) was not effective in reducing the DNA damage only in CHO-xrs5 cells. However, the pre-treatment protocol (β-glucan before UV exposition) was effective in reducing DNA damage only in CHO-K1 cells. In post-treatment (β-glucan after UV exposition) did not show significative anticlastogenic effects, although there was a tendency toward prevention. The data suggest that β-glucan has more than one action mechanism, being capable of exerting desmutagenic as well as bio-antimutagenic action. The findings also suggest that the presence of the xenobiotic metabolizing system can reduce the chemopreventive capacity of β-glucan. Therefore, these results indicate that β-glucan from Saccharomyces cerevisiae can be used in the prevention and/or reduction of DNA damage.

Entities:  

Year:  2012        PMID: 22684537      PMCID: PMC3536881          DOI: 10.1007/s10616-012-9448-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  29 in total

Review 1.  Mechanisms of inhibitors of mutagenesis and carcinogenesis.

Authors:  S De Flora
Journal:  Mutat Res       Date:  1998-06-18       Impact factor: 2.433

Review 2.  Desmutagens and bio-antimutagens--their modes of action.

Authors:  T Kada; K Shimoi
Journal:  Bioessays       Date:  1987-09       Impact factor: 4.345

Review 3.  Epidemiologic studies of antioxidants and cancer in humans.

Authors:  E W Flagg; R J Coates; R S Greenberg
Journal:  J Am Coll Nutr       Date:  1995-10       Impact factor: 3.169

Review 4.  beta-Glucans in promoting health: prevention against mutation and cancer.

Authors:  Mário S Mantovani; Marilanda F Bellini; José Pedro F Angeli; Rodrigo J Oliveira; Ariane F Silva; Lúcia R Ribeiro
Journal:  Mutat Res       Date:  2007-08-03       Impact factor: 2.433

5.  A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes.

Authors:  J W Zimmerman; J Lindermuth; P A Fish; G P Palace; T T Stevenson; D E DeMong
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

6.  The effect of (1-->3)-beta-D-glucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro.

Authors:  Lukas Kubala; Jana Ruzickova; Kristina Nickova; Jozef Sandula; Milan Ciz; Antonin Lojek
Journal:  Carbohydr Res       Date:  2003-11-21       Impact factor: 2.104

7.  Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.

Authors:  Hong Lin; Yu-Hong She; Barrie R Cassileth; Frank Sirotnak; Susanna Cunningham Rundles
Journal:  Int Immunopharmacol       Date:  2004-01       Impact factor: 4.932

Review 8.  Antimutagenic and anticarcinogenic activity of tea polyphenols.

Authors:  Y Kuroda; Y Hara
Journal:  Mutat Res       Date:  1999-01       Impact factor: 2.433

9.  Fungal beta-(1-3)-D-glucan derivatives exhibit high antioxidative and antimutagenic activity in vitro.

Authors:  Lívia Krizková; Zdena Duracková; Jozef Sandula; Darina Slamenová; Vlasta Sasinková; Monika Sivonová; Juraj Krajcovic
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

10.  Protective effects of fungal (1-->3)-beta-D-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells.

Authors:  Darina Slamenová; Juraj Lábaj; Lívia Krizková; Grigorij Kogan; Jozef Sandula; Nikolaus Bresgen; Peter Eckl
Journal:  Cancer Lett       Date:  2003-08-20       Impact factor: 8.679

View more
  3 in total

1.  Effects of β-glucan polysaccharide revealed by the dominant lethal assay and micronucleus assays, and reproductive performance of male mice exposed to cyclophosphamide.

Authors:  Rodrigo Juliano Oliveira; João Renato Pesarini; Maria José Sparça Salles; Tatiane Yumi Nakamura Kanno; Ana Carolina Dos Santos Lourenço; Véssia da Silva Leite; Ariane Fernanda da Silva; Hevenilton José Matiazi; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Genet Mol Biol       Date:  2013-02-28       Impact factor: 1.771

2.  Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model.

Authors:  Antônio Urt-Filho; Rodrigo Juliano Oliveira; Larissa Correa Hermeto; João Renato Pesarini; Natan de David; Wilson de Barros Cantero; Gustavo Falcão; Guido Marks; Andréia Conceição Milan Brochado Antoniolli-Silva
Journal:  Genet Mol Biol       Date:  2016-06-03       Impact factor: 1.771

3.  In vivo evaluation of the antimutagenic and antigenotoxic effects of β-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses.

Authors:  Rodrigo Juliano Oliveira; Maria José Sparça Salles; Ariane Fernanda da Silva; Tatiane Yumi Nakamura Kanno; Ana Carolina Dos Santos Lourenço; Véssia da Silva Leite; Hevenilton José Matiazi; João Renato Pesarini; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Genet Mol Biol       Date:  2013-07-19       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.